Table 2.
Total | Platinum sensitive | Platinum resistant | |
---|---|---|---|
Number of patients | 73 | 11 | 62 |
Best overall response: n (%) | |||
CR | 2 (2.7) | 0 (0.0) | 2 (3.2) |
PR | 14 (19.2) | 3 (27.3) | 11 (17.7) |
SD | 28 (38.4) | 3 (27.3) | 25 (40.3) |
PD | 27 (37.0) | 4 (36.4) | 23 (37.1) |
NE | 2 (2.7) | 1 (9.1) | 1 (1.6) |
Response rate | |||
n (%) (95% CI) | 16 (21.9) (13.1–33.1) | 3 (27.3) (6.0–61.0) | 13 (21.0) (11.7–33.2) |
CR, complete response; PR, partial response; SD, stable disease; PD, progression disease; NE, not evaluable; 95% CI, confidence interval.